ClinicalTrials.Veeva

Menu

Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?

U

University of South Alabama (USA)

Status and phase

Terminated
Phase 3
Phase 2

Conditions

Vulvar Lichen Sclerosus

Treatments

Drug: Topical steroid
Device: MonaLisa Touch

Study type

Interventional

Funder types

Other

Identifiers

NCT05243563
1731682-3

Details and patient eligibility

About

This study will compare the effects of fractionated CO2 laser plus topical steroids versus topical steroids alone in treatment of lichen sclerosus.

Full description

Vulvar lichen sclerosus is a common benign skin condition which causes pain and itching. Topical steroids have been the main treatment. A recent study showed that fractionated CO2 laser treatment is non inferior and actually may improve subjective symptoms compared to topical steroids with no serious safety or adverse events. Because steroids reduce risk of vulvar cancer in patients with lichen sclerosus, the investigators hypothesize that steroids in addition to the fractionated laser will provide greater symptom relief while still allowing patient the benefits of steroid treatment.

Enrollment

11 patients

Sex

Female

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women with biopsy proven lichen sclerosus and significant symptoms based on Skindex-29 scores >21

Exclusion criteria

  • prior vaginal mesh or pelvic radiation
  • active genital infection
  • Current or past gynecologic malignancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

11 participants in 2 patient groups

Fractionated CO2 laser plus topical steroids
Experimental group
Description:
3 laser treatments at 6 week intervals for 6 months by a single trained operator
Treatment:
Drug: Topical steroid
Device: MonaLisa Touch
topical steroids alone
Active Comparator group
Description:
self-applied topical steroid therapy using clobetasol propionate 0.05%
Treatment:
Drug: Topical steroid

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Catera Duhon, RN, BSN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems